Providing Scholarships, Class Reunion Assistance, and More...

BioElectronics reviews Q2 financial outcomes.

BioElectronics reviews Q2 financial outcomes, publishes marketplace surveys of ActiPatch Therapy BioElectronics Company , the maker of advanced drug-free consumer medical products, today published on it is second quarter financial outcomes plus a market evaluation of it is long term follow-up surveys of customers who all are managing discomfort with ActiPatch Therapy http://diflucancost.com read more . BioElectronics registry research of 5,000+ plus users was released by the peer-examined medical journal, Pain Management.

This reporting alternative is section of the BioClinica Integrated Operational System demonstration at the 46th DIA Annual Achieving in Washington, DC at exhibits #111 and #2005 from June 14 – 16.. , , a worldwide provider of scientific trial management services, may be the first scientific technology provider to provide a reporting alternative that includes the industry-standard functionality metrics for medical trials as described by the Metrics Champion Consortium . BioClinica has supported this is of both Imaging and Clinical Trials metrics through its participation in the MCC.